Aquisição OCRELIzumab 920 mg/23 ml Sol inj Fr 23 ml SC

ID 11647693 · Portal BASE
Price
Base Price
€189,181 .00
Effective Price
€189,181 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33690000
Location
Portugal, Lisboa, Vila Franca de Xira
Bidder Count
—
Winner
ROCHE FARMACEUTICA QUIMICA LDA
NIF 500233810
Company
Dates
Publication
20 Aug 2025
Celebration
18 Aug 2025
Contracting Entity
Unidade Local de Saúde do Estuário do Tejo, E. P. E.
NIF 516487493
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 50 · MEDIUM RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
HIGH
Authority
2426
Supplier
93
Number of Awards
3
Rule
A1 repeat direct award: 3 awards within 36 months
Detected 2026-03-06